{
  "trial_id": "NCT00063232",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), baseline serum alanine aminotransferase (ALT) levels, baseline serum aspartate aminotransferase (AST) levels, baseline NASH activity score, presence of steatosis, presence of hepatocellular injury, presence of parenchymal inflammation, presence of Mallory's hyaline, presence of pericellular fibrosis, baseline liver biopsy results, baseline fasting plasma glucose levels, baseline serum creatinine levels, history of alcohol intake, history of gastrointestinal bypass surgery, history of drug-induced liver disease, history of diabetes mellitus, use of anti-diabetic drugs, presence of significant systemic illnesses, positive test for anti-HIV, history of substance abuse, pregnancy status, history of hypersensitivity reactions to metformin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Glucose tolerance",
          "baseline fasting plasma glucose levels"
        ],
        [
          "Diabetes",
          "history of diabetes mellitus"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Age",
        "baseline serum alanine aminotransferase (ALT) levels",
        "baseline serum aspartate aminotransferase (AST) levels",
        "baseline NASH activity score",
        "presence of steatosis",
        "presence of hepatocellular injury",
        "presence of parenchymal inflammation",
        "presence of Mallory's hyaline",
        "presence of pericellular fibrosis",
        "baseline liver biopsy results",
        "baseline serum creatinine levels",
        "history of alcohol intake",
        "history of gastrointestinal bypass surgery",
        "history of drug-induced liver disease",
        "use of anti-diabetic drugs",
        "presence of significant systemic illnesses",
        "positive test for anti-HIV",
        "history of substance abuse",
        "pregnancy status",
        "history of hypersensitivity reactions to metformin"
      ]
    },
    "processed-gen-response": "Age, gender, body mass index (BMI), baseline serum alanine aminotransferase (ALT) levels, baseline serum aspartate aminotransferase (AST) levels, baseline NASH activity score, presence of steatosis, presence of hepatocellular injury, presence of parenchymal inflammation, presence of Mallory's hyaline, presence of pericellular fibrosis, baseline liver biopsy results, baseline fasting plasma glucose levels, baseline serum creatinine levels, history of alcohol intake, history of gastrointestinal bypass surgery, history of drug-induced liver disease, history of diabetes mellitus, use of anti-diabetic drugs, presence of significant systemic illnesses, positive test for anti-HIV, history of substance abuse, pregnancy status, history of hypersensitivity reactions to metformin."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Baseline ALT, Baseline AST, NASH Activity Score, Steatosis Score, Hepatocellular Injury Score, Parenchymal Inflammation Score,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Region of Enrollment",
        "Glucose tolerance",
        "Diabetes"
      ],
      "remaining_candidate_features": [
        "Age",
        "Baseline ALT",
        "Baseline AST",
        "NASH Activity Score",
        "Steatosis Score",
        "Hepatocellular Injury Score",
        "Parenchymal Inflammation Score"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index, Baseline ALT, Baseline AST, NASH Activity Score, Steatosis Score, Hepatocellular Injury Score, Parenchymal Inflammation Score"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, BMI, ALT, AST, NASH activity score, Diabetes status, History of liver disease, History of alcohol consumption, History of gastrointestinal bypass surgery, History of medication use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index",
          "BMI"
        ],
        [
          "Diabetes",
          "Diabetes status"
        ]
      ],
      "remaining_reference_features": [
        "Glucose tolerance"
      ],
      "remaining_candidate_features": [
        "Age",
        "ALT",
        "AST",
        "NASH activity score",
        "History of liver disease",
        "History of alcohol consumption",
        "History of gastrointestinal bypass surgery",
        "History of medication use"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, BMI, ALT, AST, NASH activity score, Diabetes status, History of liver disease, History of alcohol consumption, History of gastrointestinal bypass surgery, History of medication use."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), serum alanine (ALT) or aspartate (AST) aminotransferase activities, NASH activity score, presence of steatohepatitis on liver biopsy, presence of Mallory's hyaline, presence of pericellular and/or sinusoidal fibrosis, history of diabetes, history of hypertension, history of hyperlipidemia, smoking status, alcohol consumption, presence of comorbidities (e.g. cardiovascular disease, chronic kidney disease).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Diabetes",
          "history of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Glucose tolerance"
      ],
      "remaining_candidate_features": [
        "Age",
        "serum alanine (ALT) or aspartate (AST) aminotransferase activities",
        "NASH activity score",
        "presence of steatohepatitis on liver biopsy",
        "presence of Mallory's hyaline",
        "presence of pericellular and/or sinusoidal fibrosis",
        "history of hypertension",
        "history of hyperlipidemia",
        "smoking status",
        "alcohol consumption",
        "presence of comorbidities (e.g. cardiovascular disease, chronic kidney disease)"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), serum alanine (ALT) or aspartate (AST) aminotransferase activities, NASH activity score, presence of steatohepatitis on liver biopsy, presence of Mallory's hyaline, presence of pericellular and/or sinusoidal fibrosis, history of diabetes, history of hypertension, history of hyperlipidemia, smoking status, alcohol consumption, presence of comorbidities (e.g. cardiovascular disease, chronic kidney disease)."
  }
}